The primary catalyst driving the sustained Eylea Market growth is the confluence of two powerful, global demographic trends: the rapid aging of the worldwide population and the escalating prevalence of type 2 diabetes. Wet Age-Related Macular Degeneration (wAMD), one of Eylea’s core indications, is intrinsically linked to age, with the risk of the disease increasing exponentially...